nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—CYP1A1—Dacarbazine—muscle cancer	0.148	0.206	CbGbCtD
Amiodarone—CYP1A2—Dacarbazine—muscle cancer	0.066	0.0921	CbGbCtD
Amiodarone—CYP3A7—Vincristine—muscle cancer	0.0631	0.0881	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0631	0.0881	CbGbCtD
Amiodarone—ABCB1—Dactinomycin—muscle cancer	0.05	0.0698	CbGbCtD
Amiodarone—CYP3A5—Vincristine—muscle cancer	0.0473	0.0661	CbGbCtD
Amiodarone—CYP3A5—Etoposide—muscle cancer	0.0434	0.0605	CbGbCtD
Amiodarone—CYP2C8—Etoposide—muscle cancer	0.0417	0.0582	CbGbCtD
Amiodarone—CYP1A2—Etoposide—muscle cancer	0.0323	0.0451	CbGbCtD
Amiodarone—ABCB1—Vincristine—muscle cancer	0.0308	0.043	CbGbCtD
Amiodarone—ABCB1—Etoposide—muscle cancer	0.0282	0.0394	CbGbCtD
Amiodarone—ABCB1—Doxorubicin—muscle cancer	0.0193	0.0269	CbGbCtD
Amiodarone—ABCB1—Methotrexate—muscle cancer	0.0186	0.026	CbGbCtD
Amiodarone—CYP3A4—Vincristine—muscle cancer	0.0185	0.0258	CbGbCtD
Amiodarone—CYP2D6—Doxorubicin—muscle cancer	0.0181	0.0253	CbGbCtD
Amiodarone—CYP3A4—Etoposide—muscle cancer	0.0169	0.0236	CbGbCtD
Amiodarone—CYP3A4—Doxorubicin—muscle cancer	0.0115	0.0161	CbGbCtD
Amiodarone—THRA—renal system—muscle cancer	0.00191	0.0482	CbGeAlD
Amiodarone—THRB—renal system—muscle cancer	0.00191	0.0482	CbGeAlD
Amiodarone—CACNA2D2—cardiac atrium—muscle cancer	0.00169	0.0427	CbGeAlD
Amiodarone—CACNA1H—smooth muscle tissue—muscle cancer	0.00159	0.0402	CbGeAlD
Amiodarone—THRA—tendon—muscle cancer	0.00149	0.0376	CbGeAlD
Amiodarone—THRB—tendon—muscle cancer	0.00149	0.0376	CbGeAlD
Amiodarone—THRB—vagina—muscle cancer	0.00138	0.0349	CbGeAlD
Amiodarone—CACNA2D2—vagina—muscle cancer	0.00137	0.0345	CbGeAlD
Amiodarone—THRB—head—muscle cancer	0.00128	0.0322	CbGeAlD
Amiodarone—THRA—head—muscle cancer	0.00128	0.0322	CbGeAlD
Amiodarone—CACNA2D2—head—muscle cancer	0.00126	0.0319	CbGeAlD
Amiodarone—THRB—testis—muscle cancer	0.00123	0.0312	CbGeAlD
Amiodarone—THRA—testis—muscle cancer	0.00123	0.0312	CbGeAlD
Amiodarone—CACNA2D2—testis—muscle cancer	0.00122	0.0308	CbGeAlD
Amiodarone—CACNA1H—testis—muscle cancer	0.000989	0.025	CbGeAlD
Amiodarone—SIGMAR1—smooth muscle tissue—muscle cancer	0.000907	0.0229	CbGeAlD
Amiodarone—CYP2A6—vagina—muscle cancer	0.00082	0.0207	CbGeAlD
Amiodarone—ADRB1—cardiac atrium—muscle cancer	0.000815	0.0206	CbGeAlD
Amiodarone—SIGMAR1—cardiac atrium—muscle cancer	0.000782	0.0198	CbGeAlD
Amiodarone—KCNH2—renal system—muscle cancer	0.000695	0.0176	CbGeAlD
Amiodarone—SIGMAR1—tendon—muscle cancer	0.000681	0.0172	CbGeAlD
Amiodarone—SIGMAR1—bone marrow—muscle cancer	0.00066	0.0167	CbGeAlD
Amiodarone—CYP2C8—renal system—muscle cancer	0.000636	0.0161	CbGeAlD
Amiodarone—SIGMAR1—vagina—muscle cancer	0.000632	0.016	CbGeAlD
Amiodarone—KCNH2—cardiac atrium—muscle cancer	0.000622	0.0157	CbGeAlD
Amiodarone—ADRB1—head—muscle cancer	0.000609	0.0154	CbGeAlD
Amiodarone—CYP1A2—renal system—muscle cancer	0.000595	0.015	CbGeAlD
Amiodarone—CYP1A1—renal system—muscle cancer	0.000587	0.0148	CbGeAlD
Amiodarone—CYP3A5—renal system—muscle cancer	0.000574	0.0145	CbGeAlD
Amiodarone—SIGMAR1—testis—muscle cancer	0.000564	0.0143	CbGeAlD
Amiodarone—Salivary hypersecretion—Doxorubicin—muscle cancer	0.000541	0.00222	CcSEcCtD
Amiodarone—Thrombophlebitis—Methotrexate—muscle cancer	0.000539	0.00221	CcSEcCtD
Amiodarone—Agitation—Vincristine—muscle cancer	0.000532	0.00218	CcSEcCtD
Amiodarone—Photosensitivity—Methotrexate—muscle cancer	0.000531	0.00218	CcSEcCtD
Amiodarone—Skin exfoliation—Doxorubicin—muscle cancer	0.000531	0.00218	CcSEcCtD
Amiodarone—Oedema—Dactinomycin—muscle cancer	0.000529	0.00217	CcSEcCtD
Amiodarone—CYP2C19—vagina—muscle cancer	0.000528	0.0133	CbGeAlD
Amiodarone—Infection—Dactinomycin—muscle cancer	0.000526	0.00215	CcSEcCtD
Amiodarone—CYP1A1—cardiac atrium—muscle cancer	0.000525	0.0133	CbGeAlD
Amiodarone—KCNH2—bone marrow—muscle cancer	0.000525	0.0133	CbGeAlD
Amiodarone—Neuropathy—Doxorubicin—muscle cancer	0.000523	0.00214	CcSEcCtD
Amiodarone—Aplastic anaemia—Doxorubicin—muscle cancer	0.000523	0.00214	CcSEcCtD
Amiodarone—Vertigo—Vincristine—muscle cancer	0.00052	0.00213	CcSEcCtD
Amiodarone—Hepatic failure—Methotrexate—muscle cancer	0.000519	0.00213	CcSEcCtD
Amiodarone—Thrombocytopenia—Dactinomycin—muscle cancer	0.000518	0.00212	CcSEcCtD
Amiodarone—Dry eye—Doxorubicin—muscle cancer	0.000514	0.00211	CcSEcCtD
Amiodarone—Erythema multiforme—Etoposide—muscle cancer	0.00051	0.00209	CcSEcCtD
Amiodarone—Renal failure acute—Methotrexate—muscle cancer	0.000505	0.00207	CcSEcCtD
Amiodarone—Anorexia—Dactinomycin—muscle cancer	0.000504	0.00207	CcSEcCtD
Amiodarone—Ecchymosis—Doxorubicin—muscle cancer	0.000503	0.00206	CcSEcCtD
Amiodarone—KCNH2—vagina—muscle cancer	0.000503	0.0127	CbGeAlD
Amiodarone—Flushing—Etoposide—muscle cancer	0.0005	0.00205	CcSEcCtD
Amiodarone—Pulmonary oedema—Doxorubicin—muscle cancer	0.000495	0.00203	CcSEcCtD
Amiodarone—Dermatitis exfoliative—Methotrexate—muscle cancer	0.000495	0.00203	CcSEcCtD
Amiodarone—Visual disturbance—Methotrexate—muscle cancer	0.000492	0.00202	CcSEcCtD
Amiodarone—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000482	0.00198	CcSEcCtD
Amiodarone—Alopecia—Etoposide—muscle cancer	0.000476	0.00195	CcSEcCtD
Amiodarone—Anaphylactic shock—Vincristine—muscle cancer	0.000473	0.00194	CcSEcCtD
Amiodarone—Oedema—Vincristine—muscle cancer	0.000473	0.00194	CcSEcCtD
Amiodarone—Infection—Vincristine—muscle cancer	0.00047	0.00192	CcSEcCtD
Amiodarone—Phlebitis—Doxorubicin—muscle cancer	0.000469	0.00192	CcSEcCtD
Amiodarone—Thrombophlebitis—Doxorubicin—muscle cancer	0.000467	0.00191	CcSEcCtD
Amiodarone—KCNH2—head—muscle cancer	0.000465	0.0117	CbGeAlD
Amiodarone—Thrombocytopenia—Vincristine—muscle cancer	0.000463	0.0019	CcSEcCtD
Amiodarone—Hepatic function abnormal—Doxorubicin—muscle cancer	0.000462	0.00189	CcSEcCtD
Amiodarone—CYP2C8—vagina—muscle cancer	0.00046	0.0116	CbGeAlD
Amiodarone—Photosensitivity—Doxorubicin—muscle cancer	0.00046	0.00189	CcSEcCtD
Amiodarone—Decreased appetite—Dactinomycin—muscle cancer	0.00046	0.00188	CcSEcCtD
Amiodarone—Dysgeusia—Etoposide—muscle cancer	0.000459	0.00188	CcSEcCtD
Amiodarone—Hyperhidrosis—Vincristine—muscle cancer	0.000457	0.00187	CcSEcCtD
Amiodarone—Fatigue—Dactinomycin—muscle cancer	0.000456	0.00187	CcSEcCtD
Amiodarone—Back pain—Etoposide—muscle cancer	0.000454	0.00186	CcSEcCtD
Amiodarone—Pain—Dactinomycin—muscle cancer	0.000452	0.00185	CcSEcCtD
Amiodarone—Anorexia—Vincristine—muscle cancer	0.000451	0.00185	CcSEcCtD
Amiodarone—Eczema—Doxorubicin—muscle cancer	0.00045	0.00184	CcSEcCtD
Amiodarone—Hepatic failure—Doxorubicin—muscle cancer	0.00045	0.00184	CcSEcCtD
Amiodarone—KCNH2—testis—muscle cancer	0.000449	0.0114	CbGeAlD
Amiodarone—Cardiac failure congestive—Doxorubicin—muscle cancer	0.000446	0.00183	CcSEcCtD
Amiodarone—Hypotension—Vincristine—muscle cancer	0.000442	0.00181	CcSEcCtD
Amiodarone—Ataxia—Methotrexate—muscle cancer	0.000439	0.0018	CcSEcCtD
Amiodarone—Renal failure acute—Doxorubicin—muscle cancer	0.000438	0.00179	CcSEcCtD
Amiodarone—Feeling abnormal—Dactinomycin—muscle cancer	0.000436	0.00179	CcSEcCtD
Amiodarone—Ill-defined disorder—Etoposide—muscle cancer	0.000435	0.00178	CcSEcCtD
Amiodarone—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000433	0.00177	CcSEcCtD
Amiodarone—Hot flush—Doxorubicin—muscle cancer	0.000432	0.00177	CcSEcCtD
Amiodarone—Liver function test abnormal—Methotrexate—muscle cancer	0.000431	0.00177	CcSEcCtD
Amiodarone—CYP3A4—renal system—muscle cancer	0.000431	0.0109	CbGeAlD
Amiodarone—Menopausal symptoms—Doxorubicin—muscle cancer	0.000428	0.00176	CcSEcCtD
Amiodarone—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000428	0.00176	CcSEcCtD
Amiodarone—Insomnia—Vincristine—muscle cancer	0.000428	0.00175	CcSEcCtD
Amiodarone—CYP1A1—vagina—muscle cancer	0.000425	0.0107	CbGeAlD
Amiodarone—Renal impairment—Doxorubicin—muscle cancer	0.000425	0.00174	CcSEcCtD
Amiodarone—Paraesthesia—Vincristine—muscle cancer	0.000424	0.00174	CcSEcCtD
Amiodarone—CYP2D6—renal system—muscle cancer	0.000424	0.0107	CbGeAlD
Amiodarone—Malaise—Etoposide—muscle cancer	0.000423	0.00173	CcSEcCtD
Amiodarone—Vertigo—Etoposide—muscle cancer	0.000422	0.00173	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00042	0.00172	CcSEcCtD
Amiodarone—Abdominal pain—Dactinomycin—muscle cancer	0.000418	0.00171	CcSEcCtD
Amiodarone—Body temperature increased—Dactinomycin—muscle cancer	0.000418	0.00171	CcSEcCtD
Amiodarone—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000417	0.00171	CcSEcCtD
Amiodarone—CYP3A5—vagina—muscle cancer	0.000416	0.0105	CbGeAlD
Amiodarone—Cardiac failure—Doxorubicin—muscle cancer	0.000414	0.0017	CcSEcCtD
Amiodarone—Decreased appetite—Vincristine—muscle cancer	0.000411	0.00168	CcSEcCtD
Amiodarone—CYP2C8—testis—muscle cancer	0.000411	0.0104	CbGeAlD
Amiodarone—Cough—Etoposide—muscle cancer	0.000409	0.00168	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Vincristine—muscle cancer	0.000408	0.00167	CcSEcCtD
Amiodarone—Fatigue—Vincristine—muscle cancer	0.000408	0.00167	CcSEcCtD
Amiodarone—Pain—Vincristine—muscle cancer	0.000404	0.00166	CcSEcCtD
Amiodarone—Constipation—Vincristine—muscle cancer	0.000404	0.00166	CcSEcCtD
Amiodarone—ABCB1—embryo—muscle cancer	0.000403	0.0102	CbGeAlD
Amiodarone—Eosinophilia—Methotrexate—muscle cancer	0.000399	0.00164	CcSEcCtD
Amiodarone—Pancreatitis—Methotrexate—muscle cancer	0.000395	0.00162	CcSEcCtD
Amiodarone—Discomfort—Etoposide—muscle cancer	0.000395	0.00162	CcSEcCtD
Amiodarone—CYP1A1—head—muscle cancer	0.000393	0.00992	CbGeAlD
Amiodarone—Hypersensitivity—Dactinomycin—muscle cancer	0.00039	0.0016	CcSEcCtD
Amiodarone—Gastrointestinal pain—Vincristine—muscle cancer	0.000387	0.00158	CcSEcCtD
Amiodarone—Confusional state—Etoposide—muscle cancer	0.000386	0.00158	CcSEcCtD
Amiodarone—Cardiac arrest—Doxorubicin—muscle cancer	0.000384	0.00157	CcSEcCtD
Amiodarone—Pancytopenia—Methotrexate—muscle cancer	0.000383	0.00157	CcSEcCtD
Amiodarone—Anaphylactic shock—Etoposide—muscle cancer	0.000383	0.00157	CcSEcCtD
Amiodarone—Infection—Etoposide—muscle cancer	0.00038	0.00156	CcSEcCtD
Amiodarone—Ataxia—Doxorubicin—muscle cancer	0.00038	0.00156	CcSEcCtD
Amiodarone—Asthenia—Dactinomycin—muscle cancer	0.00038	0.00156	CcSEcCtD
Amiodarone—Neutropenia—Methotrexate—muscle cancer	0.000377	0.00155	CcSEcCtD
Amiodarone—Thrombocytopenia—Etoposide—muscle cancer	0.000375	0.00154	CcSEcCtD
Amiodarone—Tachycardia—Etoposide—muscle cancer	0.000374	0.00153	CcSEcCtD
Amiodarone—Abdominal pain—Vincristine—muscle cancer	0.000374	0.00153	CcSEcCtD
Amiodarone—Body temperature increased—Vincristine—muscle cancer	0.000374	0.00153	CcSEcCtD
Amiodarone—Liver function test abnormal—Doxorubicin—muscle cancer	0.000373	0.00153	CcSEcCtD
Amiodarone—Skin disorder—Etoposide—muscle cancer	0.000372	0.00152	CcSEcCtD
Amiodarone—Erectile dysfunction—Methotrexate—muscle cancer	0.000371	0.00152	CcSEcCtD
Amiodarone—Hyperhidrosis—Etoposide—muscle cancer	0.00037	0.00152	CcSEcCtD
Amiodarone—Photosensitivity reaction—Methotrexate—muscle cancer	0.000368	0.00151	CcSEcCtD
Amiodarone—Anorexia—Etoposide—muscle cancer	0.000365	0.0015	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000364	0.00149	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000364	0.00149	CcSEcCtD
Amiodarone—Diarrhoea—Dactinomycin—muscle cancer	0.000362	0.00148	CcSEcCtD
Amiodarone—Pneumonia—Methotrexate—muscle cancer	0.000362	0.00148	CcSEcCtD
Amiodarone—Hypotension—Etoposide—muscle cancer	0.000358	0.00147	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000357	0.00146	CcSEcCtD
Amiodarone—Muscular weakness—Doxorubicin—muscle cancer	0.000356	0.00146	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000356	0.00146	CcSEcCtD
Amiodarone—Renal failure—Methotrexate—muscle cancer	0.000353	0.00145	CcSEcCtD
Amiodarone—Hypersensitivity—Vincristine—muscle cancer	0.000348	0.00143	CcSEcCtD
Amiodarone—Eosinophilia—Doxorubicin—muscle cancer	0.000346	0.00142	CcSEcCtD
Amiodarone—Sweating—Methotrexate—muscle cancer	0.000345	0.00141	CcSEcCtD
Amiodarone—Paraesthesia—Etoposide—muscle cancer	0.000344	0.00141	CcSEcCtD
Amiodarone—Pancreatitis—Doxorubicin—muscle cancer	0.000342	0.0014	CcSEcCtD
Amiodarone—Dyspnoea—Etoposide—muscle cancer	0.000341	0.0014	CcSEcCtD
Amiodarone—Angina pectoris—Doxorubicin—muscle cancer	0.00034	0.00139	CcSEcCtD
Amiodarone—Asthenia—Vincristine—muscle cancer	0.000339	0.00139	CcSEcCtD
Amiodarone—Vomiting—Dactinomycin—muscle cancer	0.000336	0.00138	CcSEcCtD
Amiodarone—Agranulocytosis—Methotrexate—muscle cancer	0.000336	0.00138	CcSEcCtD
Amiodarone—Rash—Dactinomycin—muscle cancer	0.000334	0.00137	CcSEcCtD
Amiodarone—Decreased appetite—Etoposide—muscle cancer	0.000333	0.00136	CcSEcCtD
Amiodarone—Pancytopenia—Doxorubicin—muscle cancer	0.000332	0.00136	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Etoposide—muscle cancer	0.000331	0.00135	CcSEcCtD
Amiodarone—Fatigue—Etoposide—muscle cancer	0.00033	0.00135	CcSEcCtD
Amiodarone—Constipation—Etoposide—muscle cancer	0.000327	0.00134	CcSEcCtD
Amiodarone—Pain—Etoposide—muscle cancer	0.000327	0.00134	CcSEcCtD
Amiodarone—Neutropenia—Doxorubicin—muscle cancer	0.000327	0.00134	CcSEcCtD
Amiodarone—Diarrhoea—Vincristine—muscle cancer	0.000323	0.00133	CcSEcCtD
Amiodarone—Hepatitis—Methotrexate—muscle cancer	0.000323	0.00132	CcSEcCtD
Amiodarone—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000319	0.00131	CcSEcCtD
Amiodarone—Weight increased—Doxorubicin—muscle cancer	0.000318	0.0013	CcSEcCtD
Amiodarone—Weight decreased—Doxorubicin—muscle cancer	0.000316	0.00129	CcSEcCtD
Amiodarone—Feeling abnormal—Etoposide—muscle cancer	0.000316	0.00129	CcSEcCtD
Amiodarone—Nausea—Dactinomycin—muscle cancer	0.000314	0.00129	CcSEcCtD
Amiodarone—Pneumonia—Doxorubicin—muscle cancer	0.000313	0.00128	CcSEcCtD
Amiodarone—Gastrointestinal pain—Etoposide—muscle cancer	0.000313	0.00128	CcSEcCtD
Amiodarone—Dizziness—Vincristine—muscle cancer	0.000313	0.00128	CcSEcCtD
Amiodarone—Visual impairment—Methotrexate—muscle cancer	0.000311	0.00128	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000309	0.00127	CcSEcCtD
Amiodarone—Renal failure—Doxorubicin—muscle cancer	0.000306	0.00125	CcSEcCtD
Amiodarone—Erythema multiforme—Methotrexate—muscle cancer	0.000305	0.00125	CcSEcCtD
Amiodarone—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000305	0.00125	CcSEcCtD
Amiodarone—ABCB1—renal system—muscle cancer	0.000305	0.0077	CbGeAlD
Amiodarone—Urticaria—Etoposide—muscle cancer	0.000304	0.00125	CcSEcCtD
Amiodarone—Jaundice—Doxorubicin—muscle cancer	0.000304	0.00124	CcSEcCtD
Amiodarone—Abdominal pain—Etoposide—muscle cancer	0.000303	0.00124	CcSEcCtD
Amiodarone—Body temperature increased—Etoposide—muscle cancer	0.000303	0.00124	CcSEcCtD
Amiodarone—Tinnitus—Methotrexate—muscle cancer	0.000301	0.00123	CcSEcCtD
Amiodarone—Vomiting—Vincristine—muscle cancer	0.000301	0.00123	CcSEcCtD
Amiodarone—Sweating—Doxorubicin—muscle cancer	0.000299	0.00122	CcSEcCtD
Amiodarone—Rash—Vincristine—muscle cancer	0.000298	0.00122	CcSEcCtD
Amiodarone—Dermatitis—Vincristine—muscle cancer	0.000298	0.00122	CcSEcCtD
Amiodarone—Headache—Vincristine—muscle cancer	0.000296	0.00121	CcSEcCtD
Amiodarone—Agranulocytosis—Doxorubicin—muscle cancer	0.000291	0.00119	CcSEcCtD
Amiodarone—Alopecia—Methotrexate—muscle cancer	0.000285	0.00117	CcSEcCtD
Amiodarone—Bradycardia—Doxorubicin—muscle cancer	0.000285	0.00117	CcSEcCtD
Amiodarone—CYP2D6—head—muscle cancer	0.000283	0.00717	CbGeAlD
Amiodarone—Hypersensitivity—Etoposide—muscle cancer	0.000282	0.00116	CcSEcCtD
Amiodarone—Erythema—Methotrexate—muscle cancer	0.000281	0.00115	CcSEcCtD
Amiodarone—Nausea—Vincristine—muscle cancer	0.000281	0.00115	CcSEcCtD
Amiodarone—Hepatitis—Doxorubicin—muscle cancer	0.00028	0.00115	CcSEcCtD
Amiodarone—Dysgeusia—Methotrexate—muscle cancer	0.000275	0.00113	CcSEcCtD
Amiodarone—Asthenia—Etoposide—muscle cancer	0.000275	0.00113	CcSEcCtD
Amiodarone—CYP2D6—testis—muscle cancer	0.000274	0.00692	CbGeAlD
Amiodarone—Back pain—Methotrexate—muscle cancer	0.000272	0.00111	CcSEcCtD
Amiodarone—Pruritus—Etoposide—muscle cancer	0.000271	0.00111	CcSEcCtD
Amiodarone—Visual impairment—Doxorubicin—muscle cancer	0.000269	0.0011	CcSEcCtD
Amiodarone—Vision blurred—Methotrexate—muscle cancer	0.000265	0.00109	CcSEcCtD
Amiodarone—Erythema multiforme—Doxorubicin—muscle cancer	0.000264	0.00108	CcSEcCtD
Amiodarone—Diarrhoea—Etoposide—muscle cancer	0.000262	0.00107	CcSEcCtD
Amiodarone—Ill-defined disorder—Methotrexate—muscle cancer	0.000261	0.00107	CcSEcCtD
Amiodarone—Tinnitus—Doxorubicin—muscle cancer	0.000261	0.00107	CcSEcCtD
Amiodarone—Flushing—Doxorubicin—muscle cancer	0.000259	0.00106	CcSEcCtD
Amiodarone—Malaise—Methotrexate—muscle cancer	0.000253	0.00104	CcSEcCtD
Amiodarone—Dizziness—Etoposide—muscle cancer	0.000253	0.00104	CcSEcCtD
Amiodarone—Vertigo—Methotrexate—muscle cancer	0.000252	0.00103	CcSEcCtD
Amiodarone—Arrhythmia—Doxorubicin—muscle cancer	0.00025	0.00102	CcSEcCtD
Amiodarone—Alopecia—Doxorubicin—muscle cancer	0.000247	0.00101	CcSEcCtD
Amiodarone—Cough—Methotrexate—muscle cancer	0.000245	0.00101	CcSEcCtD
Amiodarone—Vomiting—Etoposide—muscle cancer	0.000243	0.000998	CcSEcCtD
Amiodarone—Erythema—Doxorubicin—muscle cancer	0.000243	0.000997	CcSEcCtD
Amiodarone—Rash—Etoposide—muscle cancer	0.000241	0.000989	CcSEcCtD
Amiodarone—Dermatitis—Etoposide—muscle cancer	0.000241	0.000989	CcSEcCtD
Amiodarone—Headache—Etoposide—muscle cancer	0.00024	0.000983	CcSEcCtD
Amiodarone—Dysgeusia—Doxorubicin—muscle cancer	0.000238	0.000977	CcSEcCtD
Amiodarone—Discomfort—Methotrexate—muscle cancer	0.000236	0.000969	CcSEcCtD
Amiodarone—Back pain—Doxorubicin—muscle cancer	0.000235	0.000965	CcSEcCtD
Amiodarone—Confusional state—Methotrexate—muscle cancer	0.000231	0.000948	CcSEcCtD
Amiodarone—ABCB1—bone marrow—muscle cancer	0.00023	0.00582	CbGeAlD
Amiodarone—Anaphylactic shock—Methotrexate—muscle cancer	0.000229	0.00094	CcSEcCtD
Amiodarone—Vision blurred—Doxorubicin—muscle cancer	0.000229	0.00094	CcSEcCtD
Amiodarone—Infection—Methotrexate—muscle cancer	0.000228	0.000934	CcSEcCtD
Amiodarone—Nausea—Etoposide—muscle cancer	0.000227	0.000932	CcSEcCtD
Amiodarone—Ill-defined disorder—Doxorubicin—muscle cancer	0.000226	0.000925	CcSEcCtD
Amiodarone—Thrombocytopenia—Methotrexate—muscle cancer	0.000225	0.00092	CcSEcCtD
Amiodarone—Agitation—Doxorubicin—muscle cancer	0.000224	0.000916	CcSEcCtD
Amiodarone—Skin disorder—Methotrexate—muscle cancer	0.000223	0.000913	CcSEcCtD
Amiodarone—Hyperhidrosis—Methotrexate—muscle cancer	0.000222	0.000909	CcSEcCtD
Amiodarone—ABCB1—vagina—muscle cancer	0.000221	0.00558	CbGeAlD
Amiodarone—Malaise—Doxorubicin—muscle cancer	0.000219	0.000899	CcSEcCtD
Amiodarone—Vertigo—Doxorubicin—muscle cancer	0.000219	0.000896	CcSEcCtD
Amiodarone—Anorexia—Methotrexate—muscle cancer	0.000219	0.000896	CcSEcCtD
Amiodarone—Hypotension—Methotrexate—muscle cancer	0.000214	0.000878	CcSEcCtD
Amiodarone—Cough—Doxorubicin—muscle cancer	0.000212	0.00087	CcSEcCtD
Amiodarone—Insomnia—Methotrexate—muscle cancer	0.000207	0.00085	CcSEcCtD
Amiodarone—Anxiety—Doxorubicin—muscle cancer	0.000206	0.000846	CcSEcCtD
Amiodarone—Paraesthesia—Methotrexate—muscle cancer	0.000206	0.000844	CcSEcCtD
Amiodarone—Discomfort—Doxorubicin—muscle cancer	0.000205	0.000839	CcSEcCtD
Amiodarone—Dyspnoea—Methotrexate—muscle cancer	0.000204	0.000838	CcSEcCtD
Amiodarone—ABCB1—head—muscle cancer	0.000204	0.00515	CbGeAlD
Amiodarone—Dry mouth—Doxorubicin—muscle cancer	0.000203	0.00083	CcSEcCtD
Amiodarone—Dyspepsia—Methotrexate—muscle cancer	0.000202	0.000827	CcSEcCtD
Amiodarone—Confusional state—Doxorubicin—muscle cancer	0.0002	0.000821	CcSEcCtD
Amiodarone—Decreased appetite—Methotrexate—muscle cancer	0.000199	0.000817	CcSEcCtD
Amiodarone—Oedema—Doxorubicin—muscle cancer	0.000199	0.000814	CcSEcCtD
Amiodarone—Anaphylactic shock—Doxorubicin—muscle cancer	0.000199	0.000814	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000198	0.000812	CcSEcCtD
Amiodarone—Fatigue—Methotrexate—muscle cancer	0.000198	0.00081	CcSEcCtD
Amiodarone—Infection—Doxorubicin—muscle cancer	0.000197	0.000809	CcSEcCtD
Amiodarone—ABCB1—testis—muscle cancer	0.000197	0.00498	CbGeAlD
Amiodarone—Pain—Methotrexate—muscle cancer	0.000196	0.000804	CcSEcCtD
Amiodarone—Shock—Doxorubicin—muscle cancer	0.000195	0.000801	CcSEcCtD
Amiodarone—Thrombocytopenia—Doxorubicin—muscle cancer	0.000194	0.000797	CcSEcCtD
Amiodarone—Tachycardia—Doxorubicin—muscle cancer	0.000194	0.000794	CcSEcCtD
Amiodarone—Skin disorder—Doxorubicin—muscle cancer	0.000193	0.000791	CcSEcCtD
Amiodarone—Hyperhidrosis—Doxorubicin—muscle cancer	0.000192	0.000787	CcSEcCtD
Amiodarone—Anorexia—Doxorubicin—muscle cancer	0.000189	0.000776	CcSEcCtD
Amiodarone—Feeling abnormal—Methotrexate—muscle cancer	0.000189	0.000775	CcSEcCtD
Amiodarone—Gastrointestinal pain—Methotrexate—muscle cancer	0.000188	0.000769	CcSEcCtD
Amiodarone—Hypotension—Doxorubicin—muscle cancer	0.000186	0.000761	CcSEcCtD
Amiodarone—Urticaria—Methotrexate—muscle cancer	0.000182	0.000747	CcSEcCtD
Amiodarone—Body temperature increased—Methotrexate—muscle cancer	0.000181	0.000743	CcSEcCtD
Amiodarone—Abdominal pain—Methotrexate—muscle cancer	0.000181	0.000743	CcSEcCtD
Amiodarone—Insomnia—Doxorubicin—muscle cancer	0.00018	0.000736	CcSEcCtD
Amiodarone—Paraesthesia—Doxorubicin—muscle cancer	0.000178	0.000731	CcSEcCtD
Amiodarone—Dyspnoea—Doxorubicin—muscle cancer	0.000177	0.000726	CcSEcCtD
Amiodarone—Dyspepsia—Doxorubicin—muscle cancer	0.000175	0.000716	CcSEcCtD
Amiodarone—Decreased appetite—Doxorubicin—muscle cancer	0.000173	0.000708	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000171	0.000703	CcSEcCtD
Amiodarone—Fatigue—Doxorubicin—muscle cancer	0.000171	0.000702	CcSEcCtD
Amiodarone—Constipation—Doxorubicin—muscle cancer	0.00017	0.000696	CcSEcCtD
Amiodarone—Pain—Doxorubicin—muscle cancer	0.00017	0.000696	CcSEcCtD
Amiodarone—Hypersensitivity—Methotrexate—muscle cancer	0.000169	0.000693	CcSEcCtD
Amiodarone—Asthenia—Methotrexate—muscle cancer	0.000165	0.000674	CcSEcCtD
Amiodarone—Feeling abnormal—Doxorubicin—muscle cancer	0.000164	0.000671	CcSEcCtD
Amiodarone—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000162	0.000666	CcSEcCtD
Amiodarone—Pruritus—Methotrexate—muscle cancer	0.000162	0.000665	CcSEcCtD
Amiodarone—Urticaria—Doxorubicin—muscle cancer	0.000158	0.000647	CcSEcCtD
Amiodarone—Body temperature increased—Doxorubicin—muscle cancer	0.000157	0.000643	CcSEcCtD
Amiodarone—Abdominal pain—Doxorubicin—muscle cancer	0.000157	0.000643	CcSEcCtD
Amiodarone—Diarrhoea—Methotrexate—muscle cancer	0.000157	0.000643	CcSEcCtD
Amiodarone—Dizziness—Methotrexate—muscle cancer	0.000152	0.000622	CcSEcCtD
Amiodarone—Hypersensitivity—Doxorubicin—muscle cancer	0.000146	0.0006	CcSEcCtD
Amiodarone—Vomiting—Methotrexate—muscle cancer	0.000146	0.000598	CcSEcCtD
Amiodarone—Rash—Methotrexate—muscle cancer	0.000145	0.000593	CcSEcCtD
Amiodarone—Dermatitis—Methotrexate—muscle cancer	0.000144	0.000592	CcSEcCtD
Amiodarone—Headache—Methotrexate—muscle cancer	0.000144	0.000589	CcSEcCtD
Amiodarone—Asthenia—Doxorubicin—muscle cancer	0.000142	0.000584	CcSEcCtD
Amiodarone—Pruritus—Doxorubicin—muscle cancer	0.000141	0.000576	CcSEcCtD
Amiodarone—Nausea—Methotrexate—muscle cancer	0.000136	0.000558	CcSEcCtD
Amiodarone—Diarrhoea—Doxorubicin—muscle cancer	0.000136	0.000557	CcSEcCtD
Amiodarone—Dizziness—Doxorubicin—muscle cancer	0.000131	0.000538	CcSEcCtD
Amiodarone—Vomiting—Doxorubicin—muscle cancer	0.000126	0.000518	CcSEcCtD
Amiodarone—Rash—Doxorubicin—muscle cancer	0.000125	0.000513	CcSEcCtD
Amiodarone—Dermatitis—Doxorubicin—muscle cancer	0.000125	0.000513	CcSEcCtD
Amiodarone—Headache—Doxorubicin—muscle cancer	0.000124	0.00051	CcSEcCtD
Amiodarone—Nausea—Doxorubicin—muscle cancer	0.000118	0.000483	CcSEcCtD
